Amyris Inc (AMRS)

0.81
NASDAQ : Basic Materials
Prev Close 0.81
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.31 / 1.81
Avg Volume 4.77M
Exchange NASDAQ
Shares Outstanding 263.02M
Market Cap 220.93M
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Amyris Achieves Key Milestone In Major Drug Discovery Collaboration

Amyris Achieves Key Milestone In Major Drug Discovery Collaboration

Industry Leading µPharm Technology Platform Delivers Initial Development Work in Just Four Months for New Oncology Drug Development

Amyris Reports Third Quarter 2016 Results

Amyris Reports Third Quarter 2016 Results

Record Revenue, Lower SG&A Expenses and Strong Outlook

BIOSSANCE™ To Launch In Sephora Stores

BIOSSANCE™ To Launch In Sephora Stores

Fast Growing, Sustainable Skin Care Brand Partners with Leading Prestige Specialty Beauty Retailer to Meet Growing Consumer Demand for Sustainable Skin Care Products

Amyris Enters Collaboration With Top 10 Pharmaceutical Company For Biosynthetic Drug Discovery

Amyris Enters Collaboration With Top 10 Pharmaceutical Company For Biosynthetic Drug Discovery

Amyris's Leading µPharm™ Platform Focused on Rapid Discovery of Novel Antibiotic Compound Target

Interesting AMRS Call Options For June 2017

Interesting AMRS Call Options For June 2017

Investors in Amyris, Inc. saw new options begin trading this week, for the June 2017 expiration.

Amyris Agrees To Collaboration Terms with Leading Global Food Ingredients And Nutraceuticals Partner

Amyris Agrees To Collaboration Terms with Leading Global Food Ingredients And Nutraceuticals Partner

Includes up to $30 Million Collaboration Investment, $100 Million in Annual Revenue and Participation in Industrial Fermentation Facilities in Asia

Amyris In Partnership With Boticario Group Named Gold Winner By Cosmetics Design For Breakthrough Ingredient - Neossance® Hemisqualane

Amyris In Partnership With Boticario Group Named Gold Winner By Cosmetics Design For Breakthrough Ingredient - Neossance® Hemisqualane

Industry Recognition of Neossance and Accelerated Customer Adoption Continues to Fuel Record Sales Growth

Amyris Wins Three-Year, Multi-Million-Dollar Contract From U.S. Department Of Energy To Further Manufacturing Of Cellulose-Derived Farnesene

Amyris Wins Three-Year, Multi-Million-Dollar Contract From U.S. Department Of Energy To Further Manufacturing Of Cellulose-Derived Farnesene

Expected to Expand Global Availability of Farnesene for Variety of Applications

Amyris Reports Second Quarter 2016 Results

Amyris Reports Second Quarter 2016 Results

Strongest Operational Execution to Date while Successfully Moving the Business Beyond Biofuels

American Refining Group Invests In Novvi To Accelerate Amyris Commercialization Of Renewable Base Oil And Lubricant Platform

American Refining Group Invests In Novvi To Accelerate Amyris Commercialization Of Renewable Base Oil And Lubricant Platform

ARG Joins Amyris and Cosan with Equity Investment and Market Access to Accelerate Revenue Growth of Novvi High Performance, Sustainably Sourced, Renewable Lubricant Products

Demand for Aviation Biofuels Grows as Green Regulations Loom

But in a narrow field, finding suppliers may be an issue.

Amyris Fuels First Delivery Of New Airbus A350-900 Airplane For Cathay Pacific As Part Of Two-Year Biojet Agreement

Amyris Fuels First Delivery Of New Airbus A350-900 Airplane For Cathay Pacific As Part Of Two-Year Biojet Agreement

Two Year Committed Jet Fuel Supply Deal Demonstrating Continued Strong Farnesene Demand